Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julius Mayengo

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
BMC Infectious Diseases|November 3, 2025
Understanding causes of incomplete reports of adverse drug reactions associated with dolutegravir-based HIV treatment in uganda: a qualitative studyHenry Zakumumpa, Helen Byomire Ndagije, Joanitah Atuhaire, et al.
Medical Science Educator|March 27, 2025
Adequacy of Pharmacovigilance Training in the Health Professional Training Institutions in Uganda: Training Gaps and Opportunities for ImprovementRajab Kalidi, Henry Kyeyune, Sula Balikuna, et al.
BMJ Open|April 29, 2024
Navigating duplication in pharmacovigilance databases: a scoping reviewRonald Kiguba, Gerald Isabirye, Julius Mayengo, et al.
The Lancet. Global Health|September 20, 2025
Adverse drug reaction reporting with the Med Safety app in Uganda: a cluster-randomised, controlled trialRonald Kiguba, Helen B Ndagije, Norah Mwebaza, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
BMC Infectious Diseases|November 3, 2025
Understanding causes of incomplete reports of adverse drug reactions associated with dolutegravir-based HIV treatment in uganda: a qualitative studyHenry Zakumumpa, Helen Byomire Ndagije, Joanitah Atuhaire, et al.
Medical Science Educator|March 27, 2025
Adequacy of Pharmacovigilance Training in the Health Professional Training Institutions in Uganda: Training Gaps and Opportunities for ImprovementRajab Kalidi, Henry Kyeyune, Sula Balikuna, et al.
BMJ Open|April 29, 2024
Navigating duplication in pharmacovigilance databases: a scoping reviewRonald Kiguba, Gerald Isabirye, Julius Mayengo, et al.
The Lancet. Global Health|September 20, 2025
Adverse drug reaction reporting with the Med Safety app in Uganda: a cluster-randomised, controlled trialRonald Kiguba, Helen B Ndagije, Norah Mwebaza, et al.
Pageof 1